Cannabinoid‐receptor expression in human leukocytes
Open Access
- 1 May 1993
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 214 (1) , 173-180
- https://doi.org/10.1111/j.1432-1033.1993.tb17910.x
Abstract
Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS), probably through the cannabinoid receptor, which has recently been cloned in rat and human. While numerous reports have also described effects of cannabinoids on the immune system, the observation of both mRNA and cannabinoid receptor has hitherto been exclusively confined to the brain, a reported detection in the testis being the sole example of its presence at the periphery. Here we report the expression of the cannabinoid receptor on human immune tissues using a highly sensitive polymerase-chain-reaction-based method for mRNA quantification. We show that, although present in a much lower abundance than in brain, cannabinoid receptor transcripts are found in human spleen, tonsils and peripheral blood leukocytes. The distribution pattern displays important variations of the mRNA level for the cannabioid receptor among the main human blood cell subpopulations. The rank order of mRNA levels in these cells is B cells > natural killer cells ≥ polymorphonuclear neutrophils ≥ T8 cells > monocytes > T4 cells. Cannabinoid-receptor mRNA, which is also found in monocytic, as well as T and B leukemia cell lines but not in Jurkat cells, presents a great diversity of expression on these cells as well, B-cell lines expressing a much higher level than T-cell lines. The cannabinoid receptor PCR products from leukocytes and brain are identical both in size and sequence suggesting a strong similarity between central and peripheral cannabinoid receptors. The expression of this receptor was demonstrated on membranes of the myelomonocytic U937 cells using the synthetic cannabinoid [3H]CP-55940 as ligand. The Kd determined from Scatchard analysis was 0.1 nM and the Bmax for membranes was 525 fmol/mg protein. The demonstration of cannabinoid-receptor expression at both mRNA and protein levels on human leukocytes provides a molecular basis for cannabinoid action on these cells.Keywords
This publication has 39 references indexed in Scilit:
- Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cellsLife Sciences, 1993
- Cyclic AMP modulation of human B cell proliferative responses: Role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and lonomycinCellular Immunology, 1992
- Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse originsInternational Journal of Immunopharmacology, 1992
- Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivoJournal of Toxicology and Environmental Health, 1991
- Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitroInternational Journal of Immunopharmacology, 1991
- Differential suppression of T-cell subpopulations by THC (delta-9-tetrahydrocannabinol)International Journal of Immunopharmacology, 1990
- Differential effects of marijuana components on proliferation of spleen, lymph node and thymus cells in vitroInternational Journal of Immunopharmacology, 1987
- In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cellsInternational Journal of Immunopharmacology, 1986
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973